Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LAURA HEYNS MARIANI

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1649333717
CMS profile
409932
Location
ANN ARBOR, MI

General Payments · PY2020–2024

$34,320.78

  • Reported across 29 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$24,283.41

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Retrophin, Inc. $8,322.37 4
Otsuka America Pharmaceutical, Inc. $7,445.17 2
NOVARTIS PHARMACEUTICALS CORPORATION $5,375.00 2
CALLIDITAS THERAPEUTICS US INC. $3,140.87 4

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $1,500.00 1
PY2021 $4,557.97 3
PY2022 $27.73 1
PY2023 $3,951.67 12
PY2024 $24,283.41 12

Payment records · PY2024 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
CALLIDITAS THERAPEUTICS US INC. $675.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 1141509079 CMS
CALLIDITAS THERAPEUTICS US INC. $450.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 1141509081 CMS
CALLIDITAS THERAPEUTICS US INC. $2,000.00 04/29/2024 Consulting Fee Undisputed 01/23/2026 1141514107 CMS
CALLIDITAS THERAPEUTICS US INC. $15.87 10/24/2024 Food and Beverage Undisputed 01/23/2026 1141525496 CMS
Novartis Pharmaceuticals Corporation $2,200.00 06/21/2024 Consulting Fee Undisputed 01/23/2026 1087143058 CMS
Novartis Pharmaceuticals Corporation $3,175.00 07/31/2024 Consulting Fee Undisputed 01/23/2026 1087151964 CMS
Otsuka America Pharmaceutical, Inc. $145.17 10/24/2024 Food and Beverage Undisputed 01/23/2026 1118936126 CMS
Otsuka America Pharmaceutical, Inc. $7,300.00 12/17/2024 Consulting Fee Undisputed 01/23/2026 1118936128 CMS
Travere Therapeutics, Inc. $7,200.00 01/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1149878461 CMS
Travere Therapeutics, Inc. $238.26 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1149878449 CMS
Travere Therapeutics, Inc. $405.16 09/20/2024 Food and Beverage Undisputed 01/23/2026 1149878453 CMS
Travere Therapeutics, Inc. $478.95 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1149878457 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.